Evolving Measurement of Minimal Residual Disease in Cancer Treatment

Exploring the advancements in measuring Minimal Residual Disease (MRD) in cancer care, the speakers discuss the significance of detecting even the smallest cancer cells to potentially achieve a cure. They highlight the improvements in diagnostic techniques and the ongoing quest for undetectable MRD as a potential indicator of successful treatment outcomes.